Data / New clinical trials / Breast Neoplasms

Breast Neoplasms trials: 1,729 new since Nov 2024

Name: New Breast Neoplasms clinical trials
Creator: SpecStream
License: https://creativecommons.org/licenses/by/4.0/

The full list. New Breast Neoplasms clinical trials: 1,729 rows for $86.45, first posted on ClinicalTrials.gov from November 12, 2024 to November 9, 2026. The list gains about 75 rows a month. The new rows come each week by email, $19 a month.

Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (central contact, contact phone, contact email, sponsor class, condition groups (MeSH), interventions and 5 more), which open on your screen as soon as the payment clears and come by email. The weekly rows run until you cancel, from the link in each delivery. The rows on this page are a sample.

For agents and scripts: this list is ordered at https://specstream.ai/data/clinical-trials/condition/breast-neoplasms, and every list with its row count and price is at https://specstream.ai/data/lists.json.

Updated November 9, 2026. Source: ClinicalTrials.gov API v2 (U.S. National Library of Medicine).

1,729 clinical studies in Breast Neoplasms were first posted on ClinicalTrials.gov from November 12, 2024 to November 9, 2026; 254 have an industry sponsor and 1,312 are recruiting or about to. The newest, NCT07924527, was posted on November 9, 2026: Predicting Benefit From Anthracycline-Free Adjuvant Chemotherapy in High-Risk HER2-Negative Breast Cancer (Peking Union Medical College Hospital).

The request: Every new Breast Neoplasms clinical trial on ClinicalTrials.gov, with the sponsor, phase, sites and the listed contact. $10 of credit on sign-up, no card.

Get new trials like these Watch a sponsor

SpecStream is the live web data engine for teams and agents. It reads every new study on ClinicalTrials.gov each morning, and this page is that reading. Ask for the conditions, phases or countries you follow and each new trial arrives in your sheet, CRM, Slack or agent with the sponsor, the sites and the listed contact.

1,729New trials
254Industry sponsored
1,312Recruiting or not yet
November 9, 2026Latest posted

Newest trials

The newest 100 of 1,729, each linked to its record. The full list holds every one with the sponsor class, interventions, start date and the central contact as the record prints it.

First posted	NCT ID	Title	Sponsor	Phase	Status	Conditions	Enrollment	Countries	Source
November 9, 2026	NCT07924527	Predicting Benefit From Anthracycline-Free Adjuvant Chemotherapy in High-Risk HER2-Negative Breast Cancer	Peking Union Medical College Hospital	Observational	Active not recruiting	Breast Neoplasms, HER2-negative Breast Cancer	100	China	clinicaltrials.gov
November 6, 2026	NCT07923643	Effect of Pectoral Nerve Block (PECS) Using Magnesium Sulfate Added to Dexamethasone on Quality of Recovery and Chronic Post-Mastectomy Pain	Assiut University	Not applicable	Not yet recruiting	Breast Cancer, Postoperative Pain, Chronic Postoperative Pain, Quality of Recovery	60	Egypt	clinicaltrials.gov
November 6, 2026	NCT07923214	A Phase I Study of CG-7321 Monotherapy or Combination Therapy in Advanced Solid Tumors	Chengdu Cynogen Bio-pharmaceutical Tech. Co., Ltd.	Phase 1	Recruiting	Advanced Solid Tumors, Breast Cancer, Ovarian Cancer, Gastric Cancer, Other Solid Tumors	30	China	clinicaltrials.gov
November 5, 2026	NCT07920094	Comparison of the Safety and Aesthetic Outcomes of a Novel Endoscopic-Assisted Breast-Conserving Surgery (SRRSHzb-EABCS) With Those of...	Sir Run Run Shaw Hospital	Not applicable	Recruiting	Breast Cancer	422	China	clinicaltrials.gov
November 5, 2026	NCT07919730	Rowing-Based Exercise Intervention on Health and Quality of Life in Breast Cancer Survivors	Università Cattolica di Milano	Not applicable	Completed	Breast Cancer, Breast Cancer Survivors	20	Italy	clinicaltrials.gov
November 5, 2026	NCT07918989	A Study of Different Skin Care Approaches to Prevent Skin Reactions in People With Breast Cancer Receiving Radiation Therapy After...	Memorial Sloan Kettering Cancer Center	Phase 2	Recruiting	Breast Cancer, Breast Cancer Female	138	United States	clinicaltrials.gov
November 5, 2026	NCT07918079	Netupitant/Palonosetron for Prevention of Nausea and Vomiting in Breast Cancer ADC Therapy	Fudan University	Phase 2	Not yet recruiting	Breast Cancer	84		clinicaltrials.gov
November 5, 2026	NCT07917845	Evaluation of Massage Therapy for Cancer Related Fatigue in Breast Cancer Survivors	Wake Forest University Health Sciences	Not applicable	Not yet recruiting	Breast Cancer, Fatigue in Cancer Survivors	34	United States	clinicaltrials.gov
November 4, 2026	NCT07917117	Improved Facial Skin Quality and Quality of Life After VYC-12L Treatment in Breast Cancer Survivors	Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia	Observational	Recruiting	Quality of Life, Breast Neoplasms, Skin Aging, Hyaluronic Acid	50	Spain	clinicaltrials.gov
November 4, 2026	NCT07917026	Continuous Controlled Cooling for Prevention of Chemotherapy-Induced Peripheral Neuropathy	Vastra Gotaland Region	Not applicable	Not yet recruiting	Chemotherapy Induced Peripheral Neuropathy (CIPN)	148	Sweden	clinicaltrials.gov
November 4, 2026	NCT07916714	Breast Cancer Real-World Insights and Decision Guidance Evaluation in Hong Kong	AstraZeneca	Observational	Not yet recruiting	Breast Neoplasms	48,000		clinicaltrials.gov
November 4, 2026	NCT07916337	3D Versus 2D Strain Echocardiography for Early Detection of Cardiotoxicity During Cancer Therapy	Region Skane	Observational	Recruiting	Cancer Related Cardiovascular Toxicity, Anthracycline Related Cardiotoxicity in Breast Cancer, Breast Cancer...	130	Sweden	clinicaltrials.gov
November 4, 2026	NCT07915739	Internal Mammary Node Irradiation After Neoadjuvant Systemic Therapy for Breast Cancer	Mahidol University	Phase 3	Not yet recruiting	Breast Neoplasms	1,760	Thailand	clinicaltrials.gov
November 4, 2026	NCT07915297	Safety and Biodistribution of [68Ga]Ga DOTA-5G in Subjects With Metastatic Breast Cancer (BC)	Luminance Biosciences Inc	Phase 1	Not yet recruiting	Metastatic Breast Cancer	10	Australia	clinicaltrials.gov
November 3, 2026	NCT07914309	Dexamethasone De-Escalation in Neoadjuvant Chemoimmunotherapy for Triple-Negative Breast Cancer	Washington University School of Medicine	Phase 2	Not yet recruiting	Triple Negative Breast Cancer, Triple Negative Breast Cancer (TNBC), Breast Cancer	17	United States	clinicaltrials.gov
November 3, 2026	NCT07911631	Effects of a Mindful Self-Compassion Intervention on Psychological Adjustment in Breast Cancer Survivors	Chung Yuan Christian University	Not applicable	Recruiting	Breast Cancer	80	Taiwan	clinicaltrials.gov
November 2, 2026	NCT07910565	Prospective Study to Evaluate the Clinical Utility of ctDNA Tumor Fraction (TF) for Detection of Estrogen Receptor 1 (ESR1) Mutations in...	Yale University	Not applicable	Not yet recruiting	Breast Cancer, Metastatic Breast Cancer, HR+/HER- Metastatic Breast Cancer	155	United States	clinicaltrials.gov
November 2, 2026	NCT07909889	Semaglutide for Weight Management During Hormone Therapy for Early Breast Cancer	Aarhus University Hospital	Phase 2	Not yet recruiting	Breast Cancer (Early Breast Cancer), Obesity	32	Denmark	clinicaltrials.gov
November 2, 2026	NCT07909785	AKU Study - Acupuncture for Aromatase Inhibitor-Induced Musculoskeletal Syndrome	Masaryk Memorial Cancer Institute	Not applicable	Active not recruiting	Aromatase Inhibitor-Associated Musculoskeletal Syndrome, Arthralgia Syndrome, Early Breast Cancer (EBC)	200	Czechia	clinicaltrials.gov
November 2, 2026	NCT07909408	Psilocybin FCR Early-Stage Breast Cancer	NYU Langone Health	Phase 2	Not yet recruiting	Early-stage Breast Cancer, Fear of Cancer Recurrence, Anxiety, Depression	100	United States	clinicaltrials.gov
October 30, 2026	NCT07907419	Effect of a Health Belief Model Based Digital Nudge Intervention on Breast Cancer Screening	Ataturk University	Not applicable	Not yet recruiting	Breast Cancer Screening, Breast Cancer Awareness, Health Belief Model	64	Turkey (Türkiye)	clinicaltrials.gov
October 30, 2026	NCT07907354	Low-Dose Apatinib Plus Chemotherapy in ADC-Pretreated HER2-Positive and HER2-Low Advanced Breast Cancer	Yunnan Cancer Hospital	Phase 2	Not yet recruiting	Breast Neoplasms, Advanced Breast Cancer, HER2-positive Breast Cancer, HER2-low Breast Cancer	56		clinicaltrials.gov
October 30, 2026	NCT07906990	Culinary And Lifestyle Medicine Education for Cancer Risk Reduction in Survivors of Breast Cancer	Case Comprehensive Cancer Center	Not applicable	Not yet recruiting	Breast Cancer	44	United States	clinicaltrials.gov
October 29, 2026	NCT07905313	Study of Trastuzumab Deruxtecan in Combination With Stereotactic Radiosurgery in Patients With HER2-Positive Metastatic Breast Cancer and...	Azienda Ospedaliero-Universitaria Careggi	Phase 2	Not yet recruiting	Breast Cancer (Advanced/Metastatic)	60		clinicaltrials.gov
October 29, 2026	NCT07905001	A Phase 1/1b Study of PRT13722 in Participants With Advanced HR+/HER2- Breast Cancer	Prelude Therapeutics Incorporated	Phase 1	Recruiting	Breast Cancer, Hormone-receptor-positive Breast Cancer, HER2-negative Breast Cancer, HR-positive Breast Cancer...	242	United States	clinicaltrials.gov
October 29, 2026	NCT07902661	Impact of Intraoperative Neurotization on Sensory Recovery of the Nipple and Breast Skin in Patients Undergoing Nipple Sparing Mastectomy...	Gangnam Severance Hospital	Not applicable	Not yet recruiting	Breast Cancer	110		clinicaltrials.gov
October 28, 2026	NCT07900516	A Prospective, Phase II, Exploratory Study Protocol of a Chemotherapy Sensitivity-based Culmerciclib Combination Regimen in Neoadjuvant...	The First Affiliated Hospital with Nanjing Medical University	Phase 2	Recruiting	Breast Cancer	48	China	clinicaltrials.gov
October 28, 2026	NCT07899892	A Study of 68Ga-FAPI Breast PET/MRI Scans in People With Breast Cancer	Memorial Sloan Kettering Cancer Center	Phase 1	Recruiting	Breast Cancer, Invasive Breast Cancer	10	United States	clinicaltrials.gov
October 27, 2026	NCT07899463	ESR1 Mutations in Metastatic Hormone Receptor-Positive Breast Cancer in the Greek Population	Hellenic Cooperative Oncology Group	Observational	Recruiting	ESR1 Gene Mutation, Breast Cancer (Locally Advanced or Metastatic), Hormon Receptor Positive Breast Cancer	500	Greece	clinicaltrials.gov
October 27, 2026	NCT07899151	Decision Support for Chemoprevention	Columbia University	Not applicable	Recruiting	Breast Cancer	240	United States	clinicaltrials.gov
October 27, 2026	NCT07899099	Mecapegfilgrastim for Prevention of Chemotherapy-Induced Neutropenia in Advanced Breast Cancer	Zheng Yabing	Observational	Recruiting	Breast Cancer, Chemotherapy-induced Neutropenia	200	China	clinicaltrials.gov
October 27, 2026	NCT07899047	Albumin-Bound Paclitaxel (Ⅱ) in Patients With Advanced Breast Cancer	Union Hospital, Tongji Medical College, Huazhong University of Science and Technology	Observational	Not yet recruiting	Breast Cancer, HER2-negative Breast Cancer, Advanced Breast Cancer	1,372	China	clinicaltrials.gov
October 27, 2026	NCT07898943	Evaluation of the Effect of Antibiotic Prophylaxis During Lumpectomy for Breast Cancer: Prospective Randomised Double-blind Noninferiority...	University Hospital, Clermont-Ferrand	Phase 3	Not yet recruiting	Breast Cancer, Breast Surgery, Surgical Site Infection (SSI), Surgical Site Infection Prevention	1,600	France	clinicaltrials.gov
October 27, 2026	NCT07898410	Clinical Trial of an Upper Limb Measurement Device	Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University	Not applicable	Completed	Upper Limb Volume Measurement	220	China	clinicaltrials.gov
October 27, 2026	NCT07897890	Testing Health-Related Interventions: Voices of Equity Needed to Overcome Weight-bias in Obesity-Cancer Care	Indiana University	Not applicable	Completed	Obesity & Overweight, Breast Cancer	12	United States	clinicaltrials.gov
October 27, 2026	NCT07897721	A Study to Learn About the Study Medicine Called PF-08165784 in People With PIK3CA-Mutated Advanced or Metastatic Solid Tumors	Pfizer	Phase 1	Not yet recruiting	Advanced Breast Cancer, Advanced or Metastatic Breast Cancer, Metastatic Breast Cancer (HR+/ HER2-), Metastatic...	268		clinicaltrials.gov
October 27, 2026	NCT07897344	Short-Term Reduced Dietary Protein in ER+/HER2- Breast Cancer Patients During Neoadjuvant Chemotherapy	Josephine Connolly-Schoonen	Not applicable	Recruiting	Breast Cancer, Hormone Receptor Positive / HER2-negative Breast Cancer	15	United States	clinicaltrials.gov
October 27, 2026	NCT07896772	Anti-Müllerian Hormone in Breast Cancer Clinical Practice	Masaryk Memorial Cancer Institute	Observational	Recruiting	Breast Cancer	200	Czechia	clinicaltrials.gov
October 27, 2026	NCT07896668	Pucotenlimab and Anlotinib in Combination With Chemotherapy	Zhejiang Cancer Hospital	Phase 2	Recruiting	Breast Cancer	34	China	clinicaltrials.gov
October 26, 2026	NCT07895511	A Study of Skipping Radiation Therapy in People With Breast Cancer	Memorial Sloan Kettering Cancer Center	Not applicable	Recruiting	HER2-positive Breast Cancer, Breast Cancer	136	United States	clinicaltrials.gov
October 26, 2026	NCT07895160	Organ Culture for Endocrine Resistant Next Line: A Treatment Selection Study in Metastatic Breast Cancer	Tel-Aviv Sourasky Medical Center	Not applicable	Recruiting	Metastatic Breast Cancer, Hormon Receptor Positive Breast Cancer	39	Israel	clinicaltrials.gov
October 26, 2026	NCT07894328	A Phase III Clinical Study of HRS-6209 Plus Letrozole as First-line Therapy in Patients With Advanced or Metastatic Breast Cancer	Jiangsu HengRui Medicine Co., Ltd.	Phase 3	Not yet recruiting	Breast Cancer	1,050	China	clinicaltrials.gov
October 26, 2026	NCT07894133	Gait Parameters in Breast Cancer Receiving Chemotherapy Patients	Adly A Adam	Observational	Recruiting	Breast Cancer, Chemotherapy, Biodex Gait Trainer, Gait Parameters	360	Egypt	clinicaltrials.gov
October 26, 2026	NCT07893730	Mapping the Enhanced Landscape of Advanced Breast Cancer fOr DYnamic Treatment Approaches	University College Cork	Phase 2	Not yet recruiting	Breast Cancer, Metastatic Breast Cancer, Locally Advanced Breast Cancer (LABC)	50		clinicaltrials.gov
October 23, 2026	NCT07893327	Evaluation of the Effect of Regular Physical Exercise in Breast Cancer.	Fundación Investigación E Innovación Biomédica Hospital Universitario Infanta Sofia-Henares	Not applicable	Recruiting	Breast Cancer Early Stage Breast Cancer (Stage 1-3)	150	Spain	clinicaltrials.gov
October 23, 2026	NCT07892274	Trastuzumab Rezetecan Followed by Pyrotinib, Fulvestrant, and Dalpiciclib in HR-Positive, HER2-Positive Advanced Breast Cancer	Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University	Phase 3	Not yet recruiting	Metastatic Breast Cancer (MBC), HER2-Positive Breast Cancer, Hormone Receptor-Positive Breast Cancer	226	China	clinicaltrials.gov
October 23, 2026	NCT07892157	Cancer Patient Navigation and Readiness	Universitas Muhammadiyah Semarang	Not applicable	Completed	Breast Cancer, Breast Cancer and Rehabilitation, Transition Care, Breast Cancer - Female, Newly Diagnosed Breast Cancer	64	Indonesia	clinicaltrials.gov
October 22, 2026	NCT07890597	A Study of a Medicine Called Atirmociclib in Combination With Giredestrant in Adult Participants With ER-positive, HER2-negative...	Pfizer	Phase 3	Not yet recruiting	Early Breast Cancer, Estrogen Receptor Positive (ER+), Human Epidermal Growth Factor Receptor 2 Negative (HER2-)	3,800		clinicaltrials.gov
October 22, 2026	NCT07889115	Evaluation of the Effect of Amantadine in the Prevention of Paclitaxel-Induced Peripheral Neuropathy in Breast Cancer Patients	Al-Azhar University	Phase 2	Not yet recruiting	Breast Cancer, Peripheral Neuropathy Due to Chemotherapy, VAS Score	80		clinicaltrials.gov
October 22, 2026	NCT07888881	An Overview of Vaccination Coverage Among Patients Receiving Treatment for Breast Cancer at the ICO: Identifying Factors Associated With...	Institut Cancerologie de l'Ouest	Observational	Not yet recruiting	Breast Cancer	312		clinicaltrials.gov
October 21, 2026	NCT07884968	Multimodal Respiratory Physiotherapy in Women Receiving Radiotherapy for Breast Cancer (RESPIRA-BC)	University of Alcala	Not applicable	Completed	Breast Neoplasms	22	Spain	clinicaltrials.gov
October 20, 2026	NCT07884487	Surgical Margin Assessment Using Intra-operative High-resolution PET/CT in Patients With Cancers Referred to Surgical Resection, an...	Cliniques universitaires Saint-Luc- Université Catholique de Louvain	Not applicable	Active not recruiting	Breast Cancer, Head and Neck Cancers, Lung Cancer, Sarcoma, Liver Metastases From Colorectal Cancer, Gastro Intestinal...	250	Belgium	clinicaltrials.gov
October 20, 2026	NCT07884201	Thymalfasin Combined With Chemotherapy and Immunotherapy in TNBC Neoadjuvant Treatment	Fudan University	Phase 2	Not yet recruiting	Breast Cancer, TNBC - Triple-Negative Breast Cancer, Immunotherapy	572		clinicaltrials.gov
October 20, 2026	NCT07883512	EMBRACE (EMPA in BReast Cancer for Activity and Cardiac ProtEction)	Virginia Commonwealth University	Phase 2	Not yet recruiting	Breast Cancer, Supportive Care in Cancer	10	United States	clinicaltrials.gov
October 20, 2026	NCT07883460	Improving Combined PET/CT and MRI of the Breast Using Dedicated Breast Positioning and Image Registration	Universität Münster	Not applicable	Not yet recruiting	Breast Cancer, Breast - Female	20	Germany	clinicaltrials.gov
October 20, 2026	NCT07883109	Podcast-Based Psychosocial Support for Women Newly Diagnosed With Breast Cancer	Mei Man	Not applicable	Not yet recruiting	Breast Cancer	80		clinicaltrials.gov
October 20, 2026	NCT07882420	Role of Artificial Intelligence in Breast Cancer Screening Via Mammography	Centre Antoine Lacassagne	Not applicable	Not yet recruiting	Breast Cancer	1,222	France	clinicaltrials.gov
October 20, 2026	NCT07882147	Diagnostic Accuracy and Utility of ZTE Added to Routine MRI	Amal Ahmed Helmy	Observational	Not yet recruiting	Breast Cancer, MRI Imaging	100		clinicaltrials.gov
October 20, 2026	NCT07882069	Effect of ACTIVE-Care on Cancer-Related Fatigue, Hope, and Psychological Resilience in Adolescents With Acute Lymphoblastic Leukemia	Selcuk University	Not applicable	Completed	Cancer (Colon Cancer, Breast Cancer, Lymphoma, Chronic Lymphoma Leukemia, Multiple Myeloma), Adolescent, Resilience...	70	Turkey (Türkiye)	clinicaltrials.gov
October 19, 2026	NCT07881679	Breast MRI for Early Detection of Breast Cancer in Thuringia	Jena University Hospital	Observational	Active not recruiting	Breast Cancer	750	Germany	clinicaltrials.gov
October 19, 2026	NCT07881341	Anatomy Impact on RT Breast Cancer	Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS	Observational	Recruiting	Breast Cancer	30	Italy	clinicaltrials.gov
October 19, 2026	NCT07881237	Effect of Serratus and Pectoralis II Plane Block Versus Pectoralis II Alone on Acute Postoperative Pain After Mastectomy	Lebanese American University	Not applicable	Not yet recruiting	Mastectomy, Mastectomy Plus Axillary Lymph Node Dissection, Nerve Block; Pain Medication, Pectoralis Nerve Block...	80	Lebanon	clinicaltrials.gov
October 19, 2026	NCT07880821	Perioperative Mirogabalin for Pain Relief After Modified Radical Mastectomy	Cairo University	Not applicable	Not yet recruiting	Breast Cancer, Post Operative Pain	50		clinicaltrials.gov
October 19, 2026	NCT07880106	Multimodal Liquid-Biopsy Omics Biomarkers of Treatment Response in Breast Cancer	Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University	Observational	Not yet recruiting	Lung Cancer Non-small Cell, Colorectal Cancer, Stomach Cancer, Hepatocellular Carcinoma, Breast Cancer	2,000	China	clinicaltrials.gov
October 19, 2026	NCT07879963	Safety and Effectiveness Study of Single-Port Surgical System in Breast Tumor Surgery	haiyanli	Not applicable	Not yet recruiting	Breast Neoplasms	25		clinicaltrials.gov
October 19, 2026	NCT07879937	Artificial Intelligence Integration in Breast Cancer Screening: The ANIHTA Study	Fondazione Policlinico Universitario Agostino Gemelli IRCCS	Observational	Not yet recruiting	Breast Neoplasms	200,075	Italy	clinicaltrials.gov
October 16, 2026	NCT07878377	Screening and the Future of Enhanced MRI for Early Breast Cancer Detection	Radboud University Medical Center	Not applicable	Not yet recruiting	Breast Cancer Detection, Breast Cancer, Screening Strategy	2,628		clinicaltrials.gov
October 16, 2026	NCT07877376	Impact of Cognitive Impairment on Chronic Pain in Breast Cancer	Nadine ATTAL	Observational	Recruiting	Breast Cancer	182	France	clinicaltrials.gov
October 15, 2026	NCT07876986	Feasibility and Effectiveness of Sentinel Lymph Node Biopsy in Inflammatory Breast Cancer	Case Comprehensive Cancer Center	Not applicable	Not yet recruiting	Breast Cancer	20	United States	clinicaltrials.gov
October 15, 2026	NCT07876596	A Drug-Drug Interaction Study of Rifampicin and Oral HRS-8080	Shandong Suncadia Medicine Co., Ltd.	Phase 1	Not yet recruiting	Breast Cancer	18	China	clinicaltrials.gov
October 15, 2026	NCT07876375	UPPER EXTREMITY FUNCTION AND LYMPHEDEMA IN BREAST CANCER SURVIVORS	Pamukkale University	Observational	Completed	Breast Cancer, Breast Cancer Female	175	Turkey (Türkiye)	clinicaltrials.gov
October 15, 2026	NCT07876349	EHR Intervention to Increase HBOC Genetic Testing	Columbia University	Not applicable	Recruiting	Breast Cancer, Ovarian Cancer, Hereditary Cancer Syndrome	55	United States	clinicaltrials.gov
October 15, 2026	NCT07875244	MAMMI-BB PET for Monitoring Response to Neoadjuvant Therapy in Breast Cancer	Fudan University	Not applicable	Active not recruiting	Breast Cancer, Neoadjuvant Therapy, Axilla; Breast	1,024	China	clinicaltrials.gov
October 14, 2026	NCT07874256	Non-Contrast-Enhanced Breast MRI in the Evaluation of Newly Diagnosed Breast Cancer: A Pilot Study	Massachusetts General Hospital	Not applicable	Not yet recruiting	Breast Cancer, Breast Cancer Detection	20		clinicaltrials.gov
October 13, 2026	NCT07870148	Cross Immune Response Between Breast Carcinoma and Thyroid Autoimmunity: Impact on Prognosis and Treatment	Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico	Not applicable	Recruiting	Breast Cancer	496	Italy	clinicaltrials.gov
October 9, 2026	NCT07869186	Dermatological Effects and Quality of Life in Oncology Patients	European Institute of Oncology	Not applicable	Not yet recruiting	Breast Cancer, Ovarian Cancer, NSCLC (Non-small Cell Lung Cancer), Melanoma (Skin Cancer), Gynecological Cancer	300	Italy	clinicaltrials.gov
October 9, 2026	NCT07868159	Plant-derived Nutrients in the Prevention and Prognosis of Breast Cancer in Women.	Keda Yu	Not applicable	Active not recruiting	Breast Cancer	639	China	clinicaltrials.gov
October 9, 2026	NCT07867925	Predicting Endocrine Resistance Using Molecular Imaging and Liquid Biopsy in Metastatic Breast Cancer	Asan Medical Center	Observational	Not yet recruiting	Metastatic Breast Cancer (HR+/ HER2-)	100	South Korea	clinicaltrials.gov
October 9, 2026	NCT07867262	A Study to Evaluate the Effects of GDC-4198 in Combination With Letrozole, Fulvestrant, or Giredestrant in Participants With Locally...	Genentech, Inc.	Phase 1	Not yet recruiting	Advanced or Metastatic Breast Cancer	165		clinicaltrials.gov
October 8, 2026	NCT07865988	Efficacy of High-Dose Melatonin in Alleviating Radiotherapy-Induced Fatigue in Breast Cancer Patients	Menoufia University	Phase 2/3	Completed	Breast Cancer, Radiotherapy Induced Fatigue	51	Egypt	clinicaltrials.gov
October 8, 2026	NCT07865884	Tissue Validation of Mammographic Breast Arterial Calcification in Mastectomy Specimens	Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital	Observational	Not yet recruiting	Breast Cancer, Vascular Calcification, Coronary Artery Calcification, Atherosclerosis Cardiovascular Disease	100		clinicaltrials.gov
October 8, 2026	NCT07864909	Physical Activity Education and Quality of Life Study in Breast Cancer Chemotherapy Patients	International Hellenic University	Not applicable	Active not recruiting	Breast Cancer	115	Greece	clinicaltrials.gov
October 7, 2026	NCT07862426	Incentive Spirometry With and Without Transcutaneous Electric Diaphragmatic Stimulation in Post-mastectomy Patients	University of Lahore	Not applicable	Active not recruiting	Breast Cancer, Post-Mastectomy	58	Pakistan	clinicaltrials.gov
October 6, 2026	NCT07861932	A Phase 1/2a Study of K-1728 in Advanced Solid Tumors	KymaThera, Inc.	Phase 1/2	Not yet recruiting	Breast Neoplasms, Solid Tumors, PIK3CA Gene Mutation	110		clinicaltrials.gov
October 6, 2026	NCT07861139	Comparative Study of QL1209 and Perjeta® in Healthy Male Participants	Qilu Pharmaceutical Co., Ltd.	Phase 1	Not yet recruiting	Breast Cancer	80		clinicaltrials.gov
October 6, 2026	NCT07860866	Blood Biomarkers for Breast Cancer Treatment Response	University of Pittsburgh	Observational	Not yet recruiting	Breast Cancer (Advanced/Metastatic), ER Positive	200	United States	clinicaltrials.gov
October 5, 2026	NCT07859319	Evaluation of the Efficacy and Acceptability of a Phytotherapy Combining Devil's Claw, Blackcurrant and Meadowsweet for the Management of...	Hospices Civils de Lyon	Phase 4	Not yet recruiting	Hormone Therapy-induced Arthralgia, Phytotherapy, Symptom Management, Adjuvant Treatment, Patient Acceptability, Joint...	105	France	clinicaltrials.gov
October 5, 2026	NCT07859098	Examining a New Insomnia Treatment for People Living With Secondary Breast Cancer.	University of Strathclyde	Not applicable	Not yet recruiting	Insomnia, Breast Cancer Metastatic Breast Cancer	50	United Kingdom	clinicaltrials.gov
October 5, 2026	NCT07859046	18F-FES PET/CT in the Treatment Planning, and Response Assessment of ER-Positive Breast Cancer	Hunan Cancer Hospital	Observational	Enrolling by invitation	Breast Cancer	100	China	clinicaltrials.gov
October 5, 2026	NCT07858825	Design and Pilot Implementation of a Chatbot to Support Breast Cancer Screening Among Black Women	University of Washington	Not applicable	Not yet recruiting	Breast Cancer	873		clinicaltrials.gov
October 5, 2026	NCT07857226	Trastuzumab/Pertuzumab With Fulvestrant and Culmerciclib in HR+/HER2+ Early Breast Cancer	Hebei Medical University Fourth Hospital	Phase 2	Not yet recruiting	Breast Cancer	31		clinicaltrials.gov
October 2, 2026	NCT07856303	SHR-A1811 Versus Trastuzumab Plus Pertuzumab in ctDNA-Positive HER2-Positive Early Breast Cancer After Pathologic Complete Response	Fudan University	Phase 2	Not yet recruiting	HER2-positive Breast Cancer, Early Breast Cancer (EBC)	358	China	clinicaltrials.gov
October 2, 2026	NCT07856225	Clinical and Therapeutic Outcomes by Molecular Subtype in Breast Cancer	Fundación Santa Fe de Bogota	Observational	Recruiting	Breast Neoplasms, Triple Negative Breast Neoplasms, HER2-Positive Breast Cancer, Hormone Receptor-Positive Breast Cancer	370	Colombia	clinicaltrials.gov
October 2, 2026	NCT07856160	De-escalation of Axillary Dissection for Node-positive Breast Cancer	University of Nebraska	Not applicable	Not yet recruiting	Breast Cancer by AJCC V8 Anatomic Stage, Breast Cancer	20		clinicaltrials.gov
September 30, 2026	NCT07850869	A Real-World Observational Study of Intratumoral H101 Oncolytic Adenovirus Combined With Immune Checkpoint Inhibitors for Advanced...	Jie Yuan，MD	Observational	Recruiting	Breast Cancer (Locally Advanced or Metastatic)	15	China	clinicaltrials.gov
September 30, 2026	NCT07850323	Safety and Effectiveness of Robotic-Assisted Remote Surgery for Breast Tumors	Guangzhou Women and Children's Medical Center	Observational	Completed	Breast Neoplasms	25	China	clinicaltrials.gov
September 30, 2026	NCT07850154	Impact of Robotic Versus Endoscopic Surgery on Nipple Nerve Function Following Nipple-Sparing Mastectomy for Breast Cancer	Guangzhou Women and Children's Medical Center	Not applicable	Not yet recruiting	Breast Neoplasms	374	China	clinicaltrials.gov
September 30, 2026	NCT07848984	Chinese Herbal Acupoint Application Combined With Triple Antiemetic Therapy for Prevention of Chemotherapy-Induced Nausea and Vomiting in...	Second Affiliated Hospital, Zhejiang University, School of Medicine	Phase 2	Not yet recruiting	Breast Neoplasms	190	China	clinicaltrials.gov
September 29, 2026	NCT07848243	Clinical Investigator-Initiated Trial (IIT) of PD-L1-Targeted Radionuclide Probes	Peking University Cancer Hospital & Institute	Phase 2	Recruiting	Lung Cancer (NSCLC), Cervical Squamous Cell Cancer, Melanoma (Skin Cancer), Breast Cancer, Gastrointestinal Cancers	50	China	clinicaltrials.gov
September 29, 2026	NCT07848061	A Master Regulator of Lipid-Associated Macrophage Function in Cancer	Fondazione Policlinico Universitario Agostino Gemelli IRCCS	Observational	Not yet recruiting	Breast Cancer, Head & Neck Cancer	120	Italy	clinicaltrials.gov

Sponsors posting most

Sponsor	New trials	Latest
Fudan University	61	November 5, 2026
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University	25	October 27, 2026
Novartis Pharmaceuticals	24	September 3, 2026
Memorial Sloan Kettering Cancer Center	19	November 5, 2026
The First Affiliated Hospital with Nanjing Medical University	18	October 28, 2026
UNC Lineberger Comprehensive Cancer Center	18	July 6, 2026
Assiut University	15	November 6, 2026
Tianjin Medical University Cancer Institute and Hospital	15	September 21, 2026
European Institute of Oncology	14	October 9, 2026
Sun Yat-sen University	14	July 29, 2026
Cancer Institute and Hospital, Chinese Academy of Medical Sciences	14	June 29, 2026
AstraZeneca	13	November 4, 2026
Peking University Cancer Hospital & Institute	13	September 29, 2026
Pfizer	12	October 27, 2026
M.D. Anderson Cancer Center	12	June 5, 2026
Xijing Hospital	12	April 15, 2026
Second Affiliated Hospital, Zhejiang University, School of Medicine	11	September 30, 2026
Peking University People's Hospital	11	September 28, 2026
Institute of Oncology Ljubljana	11	July 29, 2026
Henan Cancer Hospital	11	July 16, 2026

By phase

Phase	New trials	Latest
Not applicable	721	November 6, 2026
Observational	449	November 9, 2026
Phase 2	245	November 5, 2026
Phase 3	108	November 4, 2026
Phase 1	88	November 6, 2026
Phase 1/2	67	October 6, 2026
Phase 4	28	October 5, 2026
Early phase 1	13	August 24, 2026
Phase 2/3	10	October 8, 2026

By country

Country	New trials	Latest
United States	389	November 5, 2026
China	388	November 9, 2026
Italy	114	November 5, 2026
Turkey (Türkiye)	104	October 30, 2026
France	96	October 27, 2026
Spain	94	November 4, 2026
Egypt	54	November 6, 2026
South Korea	53	October 9, 2026
Germany	49	October 20, 2026
Canada	49	September 18, 2026
Taiwan	44	November 3, 2026
Australia	42	November 4, 2026
United Kingdom	39	October 5, 2026
Japan	30	September 3, 2026
Brazil	28	September 16, 2026
Belgium	27	October 20, 2026
Greece	24	October 27, 2026
Sweden	23	November 4, 2026
Netherlands	20	July 14, 2026
Ireland	19	September 25, 2026
Singapore	18	September 22, 2026
Pakistan	17	October 7, 2026
Czechia	16	November 2, 2026
Poland	16	June 15, 2026
Russia	15	September 15, 2026

Where the register publishes

U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Condition groups are the MeSH terms ClinicalTrials.gov assigns to each study's conditions; a study with several is in several groups. Sponsor class is the register's class of the lead sponsor. The central contact is in the full list only as the record prints it. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.